ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,587,040 | -32.8% | 21,738 | +0.6% | 0.73% | -30.9% |
| Q2 2023 | $3,848,726 | +7.2% | 21,599 | -0.7% | 1.06% | -4.6% |
| Q1 2023 | $3,589,695 | +16.9% | 21,761 | +11.6% | 1.11% | +16.3% |
| Q4 2022 | $3,069,600 | -6.6% | 19,492 | -10.6% | 0.96% | -14.1% |
| Q3 2022 | $3,285,000 | -8.5% | 21,811 | -0.1% | 1.11% | -1.1% |
| Q2 2022 | $3,590,000 | -26.1% | 21,841 | +0.0% | 1.13% | -14.0% |
| Q1 2022 | $4,861,000 | -6.6% | 21,833 | -0.4% | 1.31% | -4.9% |
| Q4 2021 | $5,204,000 | +1.6% | 21,928 | -0.1% | 1.38% | -8.3% |
| Q3 2021 | $5,124,000 | +10.0% | 21,956 | -3.0% | 1.50% | +13.3% |
| Q2 2021 | $4,660,000 | +1.7% | 22,645 | +1.6% | 1.32% | -0.1% |
| Q1 2021 | $4,581,000 | -3.9% | 22,298 | +0.3% | 1.33% | -11.2% |
| Q4 2020 | $4,766,000 | +15.7% | 22,222 | -1.4% | 1.49% | -2.5% |
| Q3 2020 | $4,119,000 | -6.2% | 22,539 | -5.4% | 1.53% | -2.2% |
| Q2 2020 | $4,393,000 | -9.8% | 23,835 | -1.2% | 1.57% | -24.8% |
| Q1 2020 | $4,868,000 | +11.7% | 24,126 | +3.6% | 2.08% | +106.6% |
| Q4 2019 | $4,357,000 | +21.1% | 23,286 | +3.3% | 1.01% | +16.3% |
| Q3 2019 | $3,599,000 | +495.9% | 22,552 | +841.6% | 0.87% | +582.7% |
| Q1 2018 | $604,000 | +16.8% | 2,395 | 0.0% | 0.13% | +22.1% |
| Q4 2017 | $517,000 | +16.2% | 2,395 | 0.0% | 0.10% | +7.2% |
| Q3 2017 | $445,000 | +8.3% | 2,395 | +0.6% | 0.10% | +5.4% |
| Q2 2017 | $411,000 | +65.1% | 2,380 | +46.0% | 0.09% | +67.3% |
| Q1 2017 | $249,000 | -87.8% | 1,630 | -88.2% | 0.06% | -87.0% |
| Q4 2016 | $2,044,000 | -24.1% | 13,870 | -34.9% | 0.42% | -21.1% |
| Q3 2016 | $2,693,000 | +10.8% | 21,305 | -1.2% | 0.54% | +2.9% |
| Q2 2016 | $2,431,000 | +0.9% | 21,560 | -6.8% | 0.52% | +6.5% |
| Q1 2016 | $2,409,000 | +5.9% | 23,140 | +14.8% | 0.49% | +8.2% |
| Q4 2015 | $2,274,000 | +843.6% | 20,165 | +814.5% | 0.45% | +822.4% |
| Q3 2015 | $241,000 | +14.2% | 2,205 | 0.0% | 0.05% | +32.4% |
| Q2 2015 | $211,000 | – | 2,205 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |